Newcastle University
A motivated Clinical Fellow is sought to join a nationally recognised renal and complement therapeutics programme at Newcastle University. The role involves leading a translational research project evaluating a novel free C5 assay for monitoring terminal complement blockade in patients with atypical haemolytic uraemic syndrome (aHUS) receiving Ravulizumab. The successful candidate will work within a multidisciplinary team to determine the assay's accuracy compared to conventional testing and explore its potential for individualising treatment strategies.
Headquarters
Newcastle Upon Tyne, England, United Kingdom
Company Size
10001+ employees
Discover Newcastle University, one of the UK’s top rated research universities and a founding member of the Russell group, located in a vibrant and inclusive student city.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Newcastle University.
Right around the average for this role
Vice President, Translational Medicine
Annexon Biosciences
Senior/Principal Scientist, MPN Biology, Translational Sciences
PharmaEssentia
Director, Nephrology Research
Travere Therapeutics
Scientist/Sr Scientist
TwoStep Therapeutics
Post-Doc Research Associate
PeopleAdmin
Principal Scientist (Director) in Translational Medicine
Merck & Co., Inc.